top of page


White Feather
IndyGeneUS Expands its Biologics & Gene Target Discovery Capabilities with SanKav Pharmaceutical (CDMO) Partnership

IndyGeneUS | March 4, 2024

 Innovative biotech company IndyGeneUS has announced a groundbreaking partnership with SanKav Pharmaceuticals, a leading provider of biopharmaceutical and cell & gene therapy analytics and manufacturing services. This strategic collaboration will significantly enhance IndyGeneUS’s drug discovery capabilities and pave the way for the development of advanced therapeutics to address health disparities impacting African and Hispanic diaspora populations.

Press Release, AP News

Press Release, ABC 27

Pharmacy Shelves
White Feather
Grand Opening

SanKav Pharmaceuticals | January 9, 2023

On January 9, 2023, SanKav Pharmaceuticals officially opened its doors to start offering services in R&D, manufacturing, packaging, and analytical testing services.

The program of the day included statements from CEO and founder Sanjeev K. Gupta, guests of honor Assemblywomen Aura K. Dunn, Washington Township Mayor Matthew Murello, and Morris County Commissioner Director John Krickus. Attendees all received a site tour and finished the day with a presentation on Essential Medicines & Biotech.

White Feather
Biopharma resilience: CDMOs secure supply chain management

Cytiva | November 16, 2022

Learn how SanKav Pharmaceuticals delivers medicine to market through available components, resources and raw materials that support on-time production lines and biomanufacturing processes.

Press Release, Bioprocess Online

Screen Shot 2022-12-01 at 12.53.40 PM.png
bottom of page